TORONTO, April 3, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that the Company has amended its amended and restated master sales agreement ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance to a transcranial magnetic stimulation device as an adjunctive treatment for major ...
NeuroStar Advanced Therapy is a transcranial magnetic stimulation system that uses magnetic fields to induce neural activity in the cerebral cortex. The Food and Drug Administration (FDA) has cleared ...
QuantalX combined transcranial magnetic stimulation and EEG technology in its first-of-its-kind brain network function ...
Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...
The US Food and Drug Administration (FDA) granted 510K clearance to market a new transcranial magnetic stimulation (TMS) device, the MagVita TMS Therapy system from MagVenture, for treatment of adults ...
Add Yahoo as a preferred source to see more of our stories on Google. In the mid-1970s, a British researcher named Anthony Barker wanted to measure the speed at which electrical signals travel down ...
83% of patients who complete Transcranial Magnetic Stimulation treatment experience measurable relief and 62% experience full remission of depression symptoms The expanded label positions Neuronetics' ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results